Mortar 发表于 2025-3-28 17:06:45

http://reply.papertrans.cn/27/2658/265799/265799_41.png

Commission 发表于 2025-3-28 20:00:33

Depression and Anxiety in the Cystic Fibrosis Population,ound to be the driving force of the psychopathology. Proposed causes of depression and anxiety in CF patients include pulmonary symptoms, especially dyspnea and air hunger, as well as vitamin D deficiency, abnormal body image, social stigma, time-consuming treatment regimens, and facing their own mo

caldron 发表于 2025-3-29 02:39:33

http://reply.papertrans.cn/27/2658/265799/265799_43.png

Flu表流动 发表于 2025-3-29 03:43:18

Sleep-Disordered Breathing and Mental Illness,–70 million Americans suffer from a chronic disorder of sleep and wakefulness, hindering daily functioning and adversely affecting health. Insomnia is the most common sleep disorder, followed by sleep apnea and restless legs syndrome (RLS). Obstructive sleep apnea (OSA) is by far the most common for

phlegm 发表于 2025-3-29 10:19:15

The Impact of Comorbidities in Patients with Chronic Respiratory Diseases,is, sleep apnoea syndrome, pneumoconiosis and pleural diseases are common respiratory diseases worldwide. They present similar symptoms such as breathlessness on exertion, excess mucous production, chronic cough and wheezing. When these conditions are not adequately treated and/or become chronic may

柔美流畅 发表于 2025-3-29 12:01:38

Non-pharmacological Interventions to Manage Depression and Anxiety Associated with Chronic Respiratbut may also involve significant changes or challenges in daily activities, social relationships, self-perception and emotional functioning. The physical symptoms that are persistent in nature and the degenerative trajectories of disease contribute to psychological responses that impact the patients

Evacuate 发表于 2025-3-29 19:06:31

Pharmacological Therapy and Anxiolytics in Patients with Respiratory Diseases,th their daily activities. This section focuses primarily on antidepressant drug trials that have been conducted in patients with COPD and major depression. It will also examine the benefits of anxiolytics for this patient group. Both selective serotonin reuptake inhibitor (SSRI) and tricyclic antid

largesse 发表于 2025-3-29 23:35:05

http://reply.papertrans.cn/27/2658/265799/265799_48.png

minimal 发表于 2025-3-30 00:11:50

Book 2017 management options are outlined. Indeed recent studies indicate a far higher prevalence of depression and anxiety in patients afflicted with chronic respiratory conditions than in patients with other chronic disorders. Unlike other publications in the field of pulmonary disease, .Depression and Anx

咽下 发表于 2025-3-30 04:47:14

http://reply.papertrans.cn/27/2658/265799/265799_50.png
页: 1 2 3 4 [5] 6
查看完整版本: Titlebook: Depression and Anxiety in Patients with Chronic Respiratory Diseases; Amir Sharafkhaneh,Abebaw Mengistu Yohannes,Mark E. Book 2017 Springe